Two batches of IPS melatonin 10mg capsules recalled

Two batches of IPS melatonin 10mg capsules recalled

July 19 2018 IPS Specials is recalling two batches of its melatonin 10mg capsules, due to an...

Government considering how to implement changes to specials reimbursement

Government considering how to implement changes to specials reimbursement

May 25 2018 The government is still considering how to implement legislation passed last year...

Price of specials medicines to come under further scrutiny

Price of specials medicines to come under further scrutiny

May 9 2018 The Government says that new regulations will strengthen controls around pricing for...

Specials Drug Tariff updated for February

Specials Drug Tariff updated for February

February 2 2018 The Drug Tariffs relating to specials medicines has been updated for the February...

Special Products becomes Veriton Pharma

Special Products becomes Veriton Pharma

October 3 2017 Special Products Ltd has changed its name to Veriton Pharma Limited, to better...

  • Two batches of IPS melatonin 10mg capsules recalled

    Two batches of IPS melatonin 10mg capsules recalled

    Thursday, 19 July 2018 10:25
  • Government considering how to implement changes to specials reimbursement

    Government considering how to implement changes to specials reimbursement

    Tuesday, 29 May 2018 12:30
  • Price of specials medicines to come under further scrutiny

    Price of specials medicines to come under further scrutiny

    Wednesday, 09 May 2018 15:21
  • Specials Drug Tariff updated for February

    Specials Drug Tariff updated for February

    Friday, 02 February 2018 14:10
  • Special Products becomes Veriton Pharma

    Special Products becomes Veriton Pharma

    Tuesday, 03 October 2017 18:03

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

drug alertMay 31 2016

A drug recall for a batch of the specials product Epistatus (midazolam maleate) 10mg/ml Oromucosal Solution 5ml has been issued. The affected batch of the unlicensed product has batch number 73234 with expiry date October 2017, and was first distributed from February 24 2016.

Specials Products Ltd has issued the recall due to concerns that around half of the units have been supplied with the wrong sized neck adaptor. The device is intended to reduce the size of the opening to accommodate an oral syringe, but as it is the wrong size it will be incompatible with the syringe.

The MHRA is asking health professionals to alerts patients who may have been supplied with the affected batch. “Where a dose has already been taken from a bottle and the correct adaptor was in place, there is no need to return that unit,” says the notice.

“All unopened bottles or opened bottles with the incorrect adaptor should be returned and replaced.” However, pharmacies should ensure that new stock is available before any affected stock is returned.

Further information is available from Special Products Ltd on 01932 690325.

Links:

MHRA announcement

MHRA letter (including images of correct and incorrect adaptors)

Special Products Limited

Specials News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...